|
Myelopathies
|
222/343 (64.7%)
|
|
IVDH
|
156/222 (70.3%), representing 161 IV sites
|
|
Cervical IVDH
|
64/161 (39.8%)
|
|
C3-C4
|
37/64 (57.8%)
|
|
C4-C5
|
12/64 (18.8%)
|
|
C2-C3
|
11/64 (17.2%)
|
|
C5-C6
|
4/64 (6.2%)
|
|
Non-cervical IVDH
|
97/161 (60.2%)
|
|
T13-L1
|
20/97 (20.6%)
|
|
L2-L3
|
17/97 (17.5%)
|
|
L3-L4
|
16/97 (16.5%)
|
|
L1-L2
|
14/97 (14.5%)
|
|
T12-T13
|
10/97 (10.3%)
|
|
L4-L5
|
10/97 (10.3%)
|
|
Other locations
|
10/97 (10.3%)
|
|
Spinal arachnoid diverticulum
|
25/222 (11.3%)
|
|
Thoracic
|
22/25 (88%)
|
|
Cervical
|
3/25 (12%)
|
|
Compressive vertebral malformations
|
19/222 (8.6%)
|
|
Hemivertebra + kyphosis
|
17/19 (89.5%)
|
|
Other CVM
|
2/19 (10.5%)
|
|
Spinal neoplasia
|
7/222 (3.1%)
|
|
Syringohydromyelia
|
6/222 (2.7%)
|
|
Other myelopathies
|
9/222 (4%)
|
|
Encephalopathies
|
68/343 (19.8%)
|
|
Brain neoplasia
|
25/68 (36.8%)
|
|
Glioma
|
17/25 (68%)
|
|
Pituitary neoplasia
|
5/25 (20%)
|
|
Other neoplasias
|
3/25 (12%)
|
|
MUO/optic neuritis
|
17/68 (25%)
|
|
Idiopathic epilepsy
|
9/68 (13.2%)
|
|
Infectious encephalitis
|
8/68 (11.8%)
|
|
Metabolic
|
3/68 (4.4%)
|
|
Other encephalopathies
|
6/68 (8.8%)
|
|
Unclassified neurological conditions
|
32/343 (9.3%)
|
|
Congenital deafness
|
29/32 (90.6%)
|
|
Bilateral
|
21/29 (72.4%)
|
|
Unilateral
|
8/29 (27.6%)
|
|
Other unclassified conditions
|
3/32 (9.4%)
|
|
PNS/muscle disorders
|
21/343 (6.1%)
|
|
Otitis interna/PVS
|
14/21 (66.7%)
|
|
Myopathies
|
3/21 (14.3%)
|
|
Idiopathic vestibular syndrome
|
2/21 (9.5%)
|
|
Others PNS/muscle disorders
|
2/21 (9.5%)
|
